JPRN-UMIN000033901
Not yet recruiting
Phase 1
Feasibility and potential benefits of preoperative chemotherapy with Gemcitabine+nab/Paclitaxel in patients with resectable pancreatic cancer: a multicenter phase I/II trial (APCS-01 study). - Multicenter phase I/II study of preoperative chemotherapy with Gemcitabine and nab/Paclitaxel for resectable pancreatic cancer (APCS-01).
Hirosaki University Graduate School of Medicine0 sites30 target enrollmentSeptember 15, 2018
Conditionsresectable pancreatic cancer
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- resectable pancreatic cancer
- Sponsor
- Hirosaki University Graduate School of Medicine
- Enrollment
- 30
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Patient with the treatment history of gemcitabine or nab/paclitaxel. 2\. R0 resection is judged to be impossible. 3\. Patient with sever diarrhea. 4\. Patient with sever ascites and pleural effusion. 5\. Patient with active other cancer. 6\. Patient with sever coexisting disease. 7\. Patients with active infectious disease. 8\. Patient with remarkable abnormal electrocardiogram or sever cardiac disorder. 9\. Patient with severe psychiatric disorder. 10\. Pregnant female, lactating female, female who might be pregnant, female who hopes to be pregnant, and male who hopes the partner's pregnancy. 11\. Patient with the history of sever medication allergy. 12\. Patient with continuous systemic administration of the steroid. 13\. Patient with contraindication of gemcitabine and nab\-paclitaxel. 14\. Patient where the attending doctor judged unsuitable for safely carrying out.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Feasibility and safety of preoperative glucose control in patients with type 2 diabetes undergoing cardiovascular surgeryThe objective of this study is to investigate whether a targeted preoperative glucose control before planned cardiac surgery by i.v. insulin infusion (intensified glycemic control, ICG) versus standard care improves postoperative outcome in patients with T2DM. In addition to evaluating involved molecular mechanisms, this study should also strengthen the evidence of guidelines regarding perioperative glucose management of patients with T2DM.Therapeutic area: Body processes [G] - Metabolic Phenomena [G03]EUCTR2014-000980-42-ATMedical University Vienna40
Completed
Not Applicable
Investigating the effectiveness of a pre-operative education intervention on reducing anxiety and improving recovery among Chinese cardiac patientsISRCTN87451169niversity of Nottingham (UK)125
Recruiting
Phase 4
Clinical outcomes and safety of preoperative non-preserved steroid eye drop in trabeculectomy: A randomised controlled trialDue to COVIDᆧ pandemic,the collection and other process may be delayed. Some patients visits may be postponed.Cytokines,glaucoma,inflammation,preoperative topical steroid,steroid eye drop,trabeculectomyTCTR20201015003Ratchadapiseksompotch Fund162
Not yet recruiting
Phase 2
comparing efficacy of preoperative magnesium sulphate nebulization with ketamine nebulization in reducing incidence of severity of post operative sore throat in patient undergoing surgery under general anesthesia.,Health Condition 1: O- Medical and SurgicalHealth Condition 2: O- Medical and SurgicalCTRI/2024/04/065794dr vaishnav
Completed
Phase 1
Evaluation of the effectiveness of the preoperative administration of a single-dose preparationof azithromycin, in chest surgery.primary lung cancerJPRN-UMIN000010368Surgical Oncology, Nagasaki University Hospital50